Eisai
4523.T
#2322
Rank
NZ$14.38 B
Marketcap
NZ$50.98
Share price
-0.58%
Change (1 day)
-5.18%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): NZ$1.42

According to Eisai's latest financial reports the company's current EPS (TTM) is NZ$1.46. In 2026 the company made an earnings per share (EPS) of NZ$1.45 a decrease over its 2025 EPS that were of NZ$1.84.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026NZ$1.45-21.04%
2025NZ$1.8411.85%
2024NZ$1.64-32.63%
2023NZ$2.445.52%
2022NZ$2.31-74.01%
2021NZ$8.89-66.58%
2020NZ$26.5998.24%
2019NZ$13.4117.01%
2018NZ$11.4637.78%
2017NZ$8.32-27.62%
2016NZ$11.4935.33%
2015NZ$8.49-2.82%
2014NZ$8.74-27.66%
2013NZ$12.08-27.49%
2012NZ$16.66-12.67%
2011NZ$19.0888.08%
2010NZ$10.15-11.06%
2009NZ$11.41-390.15%
2008NZ-$3.93-127.78%
2007NZ$14.16347.11%
2006NZ$3.174.38%
2005NZ$3.037.4%
2004NZ$2.8243.03%
2003NZ$1.9725.09%
2002NZ$1.5852.67%
2001NZ$1.0369.76%
2000NZ$0.61